New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
Certain common OTC painkillers have been linked to an increased risk of high blood pressure, stroke and heart attacks.
Arrowhead Pharmaceuticals, Inc. today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult ...
News Medical on MSN
UH pharmacology professor wins $900,000 grant to develop a dual-function nanodrug for cancer
Accelerating advancements in cancer prevention and cures, Wei Gao, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback